EDP Sciences logo
Subscriber Authentication Point
Search
Menu
Home All issues Volume 25 (Mars 2009) Hors Série n° 1 Med Sci (Paris), 25 (2009) 45-52 References
Free Access
Issue
Med Sci (Paris)
Volume 25, Mars 2009
Évaluation des risques et perspectives thérapeutiques en oncologie colorectale
Page(s) 45 - 52
Section Institut national du cancer
DOI https://doi.org/10.1051/medsci/2009251s45
Published online 15 January 2009
  1. Goulard H, Boussac-Zarebska M, Ancelle-Park R, Bloch J, les médecins coordonnateurs. Évaluation épidémiologique du dépistage du cancer du côlon et du rectum. Premières campagnes du programme pilote français. Collection veille sanitaire. Dépistage des cancers 2007 : 1–5. [Google Scholar]
  2. Faivre J, Dancourt V, Lejeune C, Tazi MA, Lamour J, Gerard D, et al. Reduction in colorectal cancer mortality by fecal occult blood screening in a French controlled study. Gastroenterology 2004; 126 : 1674–80. [Google Scholar]
  3. Arrêté du 29 septembre 2006 relatif au programme de dépistage des cancers. Journal Officiel 21 décembre 2006. [Google Scholar]
  4. Ransohoff DF, Lang CA. Screening for colorectal cancer with the fecal occult blood test : a background paper. American College of Physicians. Ann Intern Med 1997; 126 : 811–22. [Google Scholar]
  5. Scholefield JH, Moss S, Sufi F, Mangham CM, Hardcastle JD. Effect of faecal occult blood screening on mortality from colorectal cancer: results from a randomised controlled trial. Gut 2002; 50 : 840–4. [Google Scholar]
  6. Kronborg O, Jørgensen OD, Fenger C, Rasmussen M. Randomized study of biennial screening with a faecal occult blood test: results after nine screening rounds. Scand J Gastroenterol 2004; 39 :846–51. [Google Scholar]
  7. Conférence de consensus. Prévention, dépistage et prise en charge des cancers du côlon. Gastroenterol Clin Biol 1998; 22 : 205–26. [Google Scholar]
  8. Enquête EDIFICE2, Etude sur les dépistages des cancers et ses facteurs de compliance, Roche Pharma 2008. [Google Scholar]
  9. Guittet L, Bouvier V, Mariotte N, Vallee JP, Arsène D, Boutreux S, et al. Comparison of a guaiac based and an immunochemical faecal occult blood test in screening for colorectal cancer in a general average risk population. Gut 2007; 56 : 210–4. [Google Scholar]
  10. Van Rossum LG, Van Rijn AF, Laheij RJ, Van Oijen MG, Fockens P, Van Krieken HH, et al. Random Comparison of Guaiac and Immunochemical Fecal Occult Blood Tests for Colorectal Cancer in a Screening Population. Gastroenterology 2008 Mar 25. [Google Scholar]
  11. Morikawa T, Kato J, Yamaji Y, Wada R, Mitsushima T, Shiratori Y. A comparison of the immunochemical fecal occult blood test and total colonoscopy in the asymptomatic population. Gastroenterology 2005; 129 : 422–8. [Google Scholar]
  12. Sun L, Wu H and Guan YS. Colonography by CT, MRI and PET/CT combined with conventional colonoscopy in colorectal cancer screening and staging. World J Gastroenterol 2008; 14 : 853–63. [Google Scholar]
  13. Pickhardt PJ, Choi JR, Hwang I, et al. Computed tomographic virtual colonoscopy to screen for colorectal neoplasia in asymptomatic adults. N Engl J Med 2003; 349 : 2191–200. [Google Scholar]
  14. Mulhall BP, Veerappan GR, Jackson JL. Meta-analysis: computed tomographic colonography. Ann Intern Med 2005; 142 : 635–50. [Google Scholar]
  15. Kim DH, Pickhart PJ, Taylor AJ, Leung WK, Winter TC, Hinshaw JL, et al. CT colonography versus colonoscopy for the detection of advanced neoplasia. N Engl J Med 2007; 357 : 1403–12. [Google Scholar]
  16. Hassan C, Zullo A, Winn S, Morini S. Cost-effectiveness of capsule endoscopy in screening for colorectal cancer. Endoscopy 2008; 40 : 414–21. [Google Scholar]
  17. Nakamura T, Terano A. Capsule endoscopy: past, present, and future. J Gastroenterol 2008; 43 : 93–9. [Google Scholar]
  18. Imperiale TF, Ransohoff DF, Itzkowitz SH, Turnbull BA, Ross ME, Colorectal Cancer Study Group. Fecal DNA versus fecal occult blood for colorectal-cancer screening in an average-risk population. N Engl J Med 2004; 351 : 2704–14. [Google Scholar]
  19. Itzkowitz SH, Jandorf L, Brand R, Rabeneck L, Schroy PC, Sontag S, et al. Improved fecal DNA test for colorectal cancer screening. Clin Gastroenterol Hepatol 2007; 5 : 111–7. [Google Scholar]
  20. Han M, Liew CT, Zhang HW, Chao S, Zheng R, Yip KT, et al. Novel blood-based, five-gene biomarker set for the detection of colorectal cancer. Clin Cancer Res 2008; 14 : 455–60. [Google Scholar]
  21. Rex DK, Eid E. Considerations regarding the present and future roles of colonoscopy in colorectal cancer prevention. Clin Gastroenterol Hepatol 2008; 6:506–14. [Google Scholar]
  22. Bressler B, Paszat LF, Chen Z, Rothwell DM, Vinden C, Rabeneck L. Rates of new or missed colorectal cancers after colonoscopy and their risk factors: a population-based analysis. Gastroenterology 2007; 132 : 96–102. [Google Scholar]
  23. Mandel SJ. Screening for colorectal cancer. Gastroenterol Clin North Am 2008; 37 : 97–115. [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.